List of works by Maria Teresa Di Martino

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.

scientific article published on 2 November 2015

A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival.

scientific article published on 16 December 2016

A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.

scientific article published in December 2014

A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.

scientific article published on 26 April 2011

Analysis of miRNA, mRNA, and TF interactions through network-based methods.

scientific article published on 4 June 2015

Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis

scientific article published on 20 November 2020

DMETTM Genotyping: Tools for Biomarkers Discovery in the Era of Precision Medicine

scientific article published on 29 March 2020

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.

scientific article published on 09 June 2016

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.

scientific article published on October 2012

Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma

scientific article

Development and validation of a bioanalytical method for quantification of LNA-i-miR-221, a 13-mer oligonucleotide, in rat plasma using LC-MS/MS.

scientific article published on 15 December 2017

EDTA is essential to recover lead from dried blood spots on filter paper.

scientific article published in December 2004

Emerging pathways as individualized therapeutic target of multiple myeloma.

scientific article published on 06 June 2013

Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment.

scientific article published on 20 December 2017

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells

scientific article published on 06 February 2019

From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario.

scientific article published on September 2013

Functional Analysis of microRNA in Multiple Myeloma

scientific article published on 14 May 2015

Genetic variants associated with Fabry disease progression despite enzyme replacement therapy

scientific article published on 18 November 2017

Genetic variants associated with gastrointestinal symptoms in Fabry disease.

scientific article published on 5 November 2016

Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis.

scientific article published on 25 November 2015

In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.

scientific article published on 21 February 2014

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma

scientific article

In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.

scientific article

Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma

scientific article published on 27 May 2015

MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells

scientific article published on 21 November 2017

Mir-221/222 are promising targets for innovative anticancer therapy.

scientific article published on 9 March 2016

Mir-34: a new weapon against cancer?

scientific article published on 23 September 2014

Molecular targets for the treatment of multiple myeloma.

scientific article published on September 2012

Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment.

scientific article

Novel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: experimental models and translational issues.

scientific article published on January 2007

Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice

scientific article published on 22 October 2020

Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates

scientific article published on 21 June 2016

Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy.

scientific article published on 5 March 2018

Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.

scientific article

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

scientific article published on 3 October 2012

Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.

scientific article

The potential role of miRNAs in multiple myeloma therapy

scientific article published on 12 September 2018

Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92

scientific article published on 11 July 2018

Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma.

scientific article published on 13 February 2014

Uncharacterized RNAs in Plasma of Alzheimer's Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power

scientific article published on 15 October 2020

miR-22 suppresses DNA ligase III addiction in multiple myeloma

scientific article published on 17 August 2018

miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.

scientific article published on 2 May 2018

miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells

scientific article published on 25 September 2013

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

scientific article published on 29 November 2012

Paulina is supported by:

About Paulina

Help